Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $1.75 | Prev. Close $1.79 | Circuit Range N/A |
Day Range $1.65 - $1.82 | Year Range $1.65 - $21.07 | Volume 1,474 |
Average Traded $1.72 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
13-Jan-26 | $1.94 | $1.83 | -6.15% |
12-Jan-26 | $1.99 | $1.95 | -3.47% |
09-Jan-26 | $2.23 | $2.02 | -14.95% |
08-Jan-26 | $2.47 | $2.38 | -15.18% |
07-Jan-26 | $3.23 | $2.80 | -1.41% |
06-Jan-26 | $2.84 | $2.84 | +0.00% |
02-Jan-26 | $2.84 | $2.84 | -1.90% |